sr141716 has been researched along with humulene in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Fur, G; Poncelet, M; Rinaldi-Carmona, M; Soubrié, P; Souilhac, J | 1 |
| Iversen, L | 1 |
| Nutt, D | 1 |
| Bridgen, DT; Lichtman, AH; Martin, BR; Tao, Q; Thomas, BF; Varvel, SA | 1 |
| Ben-Ari, Y; Bernard, C; Freund, TF; Gozlan, H; Milh, M; Morozov, YM | 1 |
| Ewan, S | 1 |
| Harloe, JP; Lichtman, AH; Martin, BR; Varvel, SA; Wilson, DM | 1 |
| Villares, J | 1 |
| Khiabani, HZ; Mørland, J | 1 |
| Griffing, GT | 1 |
| Aviello, G; Borrelli, F; Capasso, F; Capasso, R; Izzo, AA; Romano, B; Scalisi, C | 1 |
| Benwell, K; Brooks, TD; Foloppe, N; Kennett, G; Knight, AR; Misra, A; Monck, NJ | 1 |
| DeLong, GT; Lichtman, AH; Poklis, A; Wolf, CE | 1 |
| Anavi-Goffer, S; Baillie, G; Gertsch, J; Greig, IR; Irving, AJ; Pertwee, RG; Ross, RA | 1 |
| Baumann, MH; Gramling, BR; Justinova, Z; Schindler, CW; Thorndike, EB | 1 |
| Hegele, RA; Lazarte, J | 1 |
2 review(s) available for sr141716 and humulene
| Article | Year |
|---|---|
[Cannabis and cannabinoids as drugs].
Topics: Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Cognition Disorders; Dronabinol; Humans; Piperidines; Psychoses, Substance-Induced; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Risk Factors | 2007 |
Cannabis effects on lipoproteins.
Topics: Anti-Obesity Agents; Body Weight; Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Case-Control Studies; Cholesterol, HDL; Energy Intake; Gene Expression; Humans; Lipid Metabolism; Receptor, Cannabinoid, CB1; Rimonabant; Triglycerides | 2019 |
14 other study(ies) available for sr141716 and humulene
| Article | Year |
|---|---|
Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice.
Topics: Analgesics; Animals; Benzoxazines; Cannabis; Corpus Striatum; Cyclohexanols; Dose-Response Relationship, Drug; Female; Injections; Mice; Morpholines; Naphthalenes; Neurons; Oxidopamine; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Receptors, Neurokinin-2; Rimonabant; Stereoisomerism; Stereotyped Behavior | 1995 |
High times for cannabis research.
Topics: Analgesics, Non-Narcotic; Animals; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Mice; Mice, Knockout; Motor Activity; Pain Threshold; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1999 |
Cannabis antagonists: a new era of social psychopharmacology?
Topics: Anti-Obesity Agents; Cannabinoids; Cannabis; Humans; Marijuana Abuse; Obesity; Piperidines; Psychopharmacology; Pyrazoles; Rimonabant | 2005 |
Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Topics: Analgesics; Animals; Behavior, Animal; Body Temperature; Brain; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Inhalation Exposure; Injections, Intravenous; Male; Mice; Mice, Inbred ICR; Pain Measurement; Piperidines; Pyrazoles; Rimonabant; Smoke | 2005 |
Altering cannabinoid signaling during development disrupts neuronal activity.
Topics: Animals; Brain; Cannabinoid Receptor Modulators; Cannabis; Electrodes; Electrophysiology; Female; Hippocampus; Immunohistochemistry; Male; Microscopy, Electron; Neurons; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, GABA-A; Rimonabant; Signal Transduction; Substance-Related Disorders; Time Factors | 2005 |
Weeding out new drugs.
Topics: Analgesics; Anti-Obesity Agents; Cannabinoids; Cannabis; Clinical Trials as Topic; Humans; Hydrophobic and Hydrophilic Interactions; Inflammatory Bowel Diseases; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Solubility | 2005 |
SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice.
Topics: Animals; Cannabis; Male; Mice; Mice, Inbred ICR; Piperidines; Pyrazoles; Rimonabant; Substance Withdrawal Syndrome; Substance-Related Disorders | 2006 |
Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain.
Topics: Adolescent; Adult; Autoradiography; Brain; Cannabis; Case-Control Studies; Gene Expression Regulation; Humans; In Situ Hybridization; Male; Marijuana Abuse; Piperidines; Postmortem Changes; Pyrazoles; Receptors, Cannabinoid; Rimonabant; RNA, Messenger; Tritium | 2007 |
Endocannabinoids--the brain's own marijuana--may be linked to the metabolic syndrome.
Topics: Brain; Cannabinoid Receptor Modulators; Cannabis; Endocannabinoids; Humans; Metabolic Syndrome; Piperidines; Pyrazoles; Rimonabant | 2006 |
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.
Topics: Acetylcholine; Amidohydrolases; Animals; Cannabidiol; Cannabis; Cholinergic Agents; Croton Oil; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Ileitis; Ileum; Loperamide; Male; Mice; Mice, Inbred ICR; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2008 |
Discovery and functional evaluation of diverse novel human CB(1) receptor ligands.
Topics: Animals; Cannabinoids; Cannabis; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Humans; Ligands; Mice; Models, Chemical; Molecular Structure; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2009 |
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Cannabinoids; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Hypothermia; Inflammation; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2010 |
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
Topics: Allosteric Regulation; Analgesics; Cannabinoids; Cannabis; Dronabinol; HEK293 Cells; Humans; Ligands; Lysophospholipids; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neuralgia; Phosphoproteins; Phosphorylation; Piperidines; Plant Extracts; Pyrazoles; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Rimonabant | 2012 |
Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.
Topics: Animals; Body Temperature; Cannabinoids; Cannabis; Dronabinol; Indoles; Male; Naphthalenes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Spices | 2017 |